Don Chen has 30 years experience in biomedical development, including basic research at the Mayo Clinic, industrial pharmaceutical research and development at CIBA‐GEIGY/Novartis, and regulation of new drugs, devices and biologics at the FDA. As a former FDA Regulatory Expert in Pharmacology/Toxicology, he has been an outside FDA Expert Consultant for ten years and is experienced in negotiations, deal‐making in the biopharmaceutical industry, an

Carolyn Chen is an accomplished professional in pharmaceutical and health care consulting, with expertise in business development strategy and marketing. She began her career at Towers Perrin, now Towers Watson, in New York. She also worked in the Corporate Affairs Division at Pfizer with responsibility for its global infectious disease programs. She has also worked at Médecins Sans Frontières/Doctors Without Borders in its neglected diseases